Our clinical trials of tildacerfont in adults with classic CAH, CAHmelia 203 and CAHmelia 204, are open for screening | LEARN MORE


Spruce values our collaborative partnerships with the patient advocacy community. To ensure that these collaborations respect the independence of all partners and are built on integrity and trust, we align with the Bio Industry Organization’s guiding principles. These principles represent the highest industry standards for interactions with patient groups.

We amplify efforts to bring awareness to the needs of those who live with or care for someone with congenital adrenal hyperplasia and polycystic ovary syndrome.

For additional information about CAH, please visit these sites: